Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2020, and Provides Business Update
NORCROSS, Ga., Aug. 10, 2020 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target […]